Logo - springer
Slogan - springer

Medicine - Radiology | EJNMMI Research - European Journal of Nuclear Medicine and Molecular Imaging - a SpringerOpen journal (Editorial Board)

EJNMMI Research

EJNMMI Research

Editor-in-Chief: Angelika Bischof-Delaloye

ISSN: 2191-219X (electronic version)

Journal no. 13550

Editor-in-Chief
Angelika Bischof-Delaloye, University of Lausanne, Lausanne, Switzerland

Associate Editor
Ignasi Carrio, Autonomous University of Barcelona, Barcelona, Spain
Arturo Chiti, Humanitas University, Milano, Italy
Philip H. Elsinga, University Medical Center Groningen, Groningen, The Netherlands

Editorial Board
Nicolas Aide, Centre Hospitalier Universitaire de Caen, Caen, France
Manuel Bardies, INSERM-Université Toulouse, Toulouse, France
Ambros Beer, University Hospital Ulm, Ulm, Germany
Frank M. Bengel, Hannover, Germany
Ronald Boellaard, Amsterdam, The Netherlands
Francois Chatal, Nantes, France
June-Key Chung, Seoul National University Hospital, Seoul, South Korea
Alberto Cuocolo, University Federico II, Naples, Italy
Clemens Decristoforo, Innsbruck, Austria
Silvana Del Vecchio, University Federico II, Naples, Italy
Chaitanya Ramdas Divgi, Columbia University, New York, NY, USA
Annare Ellmann, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
Einat Even-Sapir, Tel Aviv, Israel
Stefano Fanti, Università di Bologna, Bologna, Italy
Alberto Flotats, Barcelona, Spain
Uwe Haberkorn, Heidelberg, Germany
Christer Halldin, Stockholm, Sweden
Karl Herholz, University of Manchester, Manchester, United Kingdom
Hossein Jadvar, University of Southern California, Los Angeles, CA, USA
Francois Jamar, University Hospital St-Luc, Brussels, Belgium
Philipp A. Kaufmann, University Hospital Zurich, Zurich, Switzerland
M. Juhani Knuuti, Turku, Finland
Francoise Kraeber-Bodéré, Nantes, France
Kazou Kubota, Southern TOHOKU General Hospital, Tokyo, Japan
Steven Larson, New York, NY, USA
Michael Lassmann, Würzburg, Germany
Dong Soo Lee, Seoul, South Korea
Giovanni Lucignani, Milano, Italy
Markus Luster, University Hospital Marburg, Marburg, Germany
Helmut R. Maecke, Universitätsklinikum Freiburg, Freiburg, Germany
Giuliano Mariani, Pisa, Italy
Pierre-Yves Marie, University Hospital of Nancy, Nancy, France
Rosa Maria Moresco, University of Milan Bicocca, Milano, Italy
Luc Mortelmans, Leuven, Belgium
Joseph A. O’Donoghue, Memorial Sloan Kettering Cancer Center, New York, USA
Wim J. G. Oyen, The Institute of Cancer Research, Sutton, UK
Francesca Pons, University of Barcelona, Barcelona, Spain
Michael Schäfers, Münster, Germany
Orazio Schillaci, University of Rome Tor Vergata, Rome, Italy
Andrew M. Scott, Melbourne, Australia
Michio Senda, Institute of Biomedical Research and Innovation, Kobe, Japan
Alberto Signore, Sapienza University, Rome, Italy
Nagara Tamaki, Kyoto Prefectural University of Medicine, Sapporo, Japan
Mustafa Ünlü, Ankara, Turkey
Alfons Verbruggen, Leuven, Belgium
Wolfgang A. Weber, Memorial Sloan Kettering Cancer Center, New York, USA
Hans-Jürgen Wester, Munich, Germany
Hong Zhang, Zheijang, China

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 2.033
  • Aims and Scope

    Aims and Scope

    Close

    EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
    The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
  • Submit Online
  • Aims and Scope
  • Instructions for Authors
  • Copyright and License Agreement